Amiodarone is an antiarrhythmic used for atrial and ventricular arrhythmias that have not responded to alternatives. It is highly effective, and it is one of the most demanding medicines in routine use. It is loaded with iodine, it accumulates in fat and tissue, and its half-life is measured in weeks to months - so its effects, including the unwanted ones, persist long after the last tablet.
Follow the plan your cardiology team gave you. This guide contains no doses.
The monitoring is the treatment
Before starting: thyroid function, liver function, kidney function, potassium, a chest X-ray and an ECG.
During treatment: thyroid and liver function every six months, at minimum, and a chest X-ray if respiratory symptoms appear.
An annual eye check is advised.
This is not optional, and if you have been on amiodarone for a year without blood tests, that is worth raising - see monitoring long-term medicines.
The thyroid, in both directions
Amiodarone is about forty per cent iodine by weight, delivering a colossal iodine load.
It causes hypothyroidism in some people and hyperthyroidism in others, and it can do either at any point during treatment or for months afterwards.
Hypothyroidism is commoner and is straightforward - levothyroxine is added and amiodarone usually continued. See levothyroxine.
Hyperthyroidism is more difficult, can be severe, and often requires stopping the drug and specialist treatment - and because amiodarone persists for months, it does not resolve quickly.
Report weight change, palpitations, tremor, heat or cold intolerance, or unusual tiredness.
The lungs
Pulmonary toxicity is the most serious complication - an inflammatory or fibrotic lung reaction that can be fatal if it progresses.
It usually develops gradually over months.
Report a new or worsening cough, breathlessness, or chest pain and mention that you take amiodarone - it changes what should be investigated, and it is easily attributed to heart failure or a chest infection instead.
Caught early and with the drug stopped, it often improves. Left alone, it may not.
The eyes
Corneal microdeposits develop in almost everyone on long-term amiodarone. They are usually harmless, may cause haloes around lights at night, and resolve after stopping.
Optic neuropathy is entirely different - rare, and a cause of permanent visual loss.
Report any change in vision, particularly blurring or loss of vision in one eye, and seek advice rather than waiting for a routine appointment.
The skin
Amiodarone causes marked photosensitivity - people burn in conditions that would normally be harmless - and with prolonged use a characteristic slate-grey or bluish discolouration of sun-exposed skin, particularly the face.
The discolouration fades very slowly after stopping and may not fully resolve.
High-factor sunscreen, covering up and avoiding sunbeds are not optional here - see medicines that make you sun-sensitive.
Interactions
Amiodarone inhibits several enzymes and transporters, and its long half-life means interactions persist after stopping.
Warfarin - the effect is substantially increased, and the warfarin dose is usually reduced when amiodarone is started. INR needs close monitoring for weeks. See warfarin.
Digoxin - levels rise markedly, and the dose is typically halved.
Statins - simvastatin doses are capped; muscle risk rises. See simvastatin.
Other QT-prolonging medicines - amiodarone prolongs QT itself, so combinations stack. See medicines that affect your heart rhythm.
Beta blockers, verapamil and diltiazem - added bradycardia. See verapamil.
Grapefruit raises amiodarone levels - see grapefruit and medicines.
Tell every prescriber that you take amiodarone, including after stopping it.
Other effects
Nausea, metallic taste and loss of appetite, particularly during loading.
Report jaundice or dark urine - liver injury occurs. Also tremor, unsteadiness, sleep disturbance, and numbness or tingling in the hands and feet, since peripheral neuropathy is recognised.
Report fainting or marked slowing of the pulse.
The loading period
Because amiodarone accumulates so slowly in tissue, it is given at a higher loading dose for a period before dropping to maintenance - otherwise it would take months to become effective.
Side effects including nausea and metallic taste are commonest during loading and often ease afterwards. It also means that a dose reduction takes weeks to show its effect, so changes are made slowly and judged patiently rather than adjusted week to week.
Why it is used despite all this
Because for some arrhythmias nothing else works as well, particularly where structural heart disease rules out the alternatives.
The decision balances a genuinely effective drug against a long list of manageable risks - and what makes that balance work is the monitoring. See atrial fibrillation.
More on what medicines are prescribed for in the Conditions section, including Ticagrelor: Why It Can Make You Breathless.